Bioinvent Intern (BOVNF) Stock Price, News & Analysis
Company Description
Bioinvent Intern (OTC Link: BOVNF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $216.4M.
BOVNF has declined 30.0% over the past year. Shares last traded at $3.29.
This page collects what Stock Titan holds for BOVNF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Bioinvent Intern (BOVNF) stock last closed at $3.29. Over the past 12 months, the stock has lost 30.0%. At a market capitalization of $216.4M, BOVNF is classified as a micro-cap stock with approximately 65.8M shares outstanding.
Latest News
Bioinvent Intern has 8 recent news articles. Key topics include clinical trial, conferences, earnings. View all BOVNF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Bioinvent Intern (BOVNF) currently stands at 20 shares, a new position with no short interest reported in the previous period. Since July 2025, short interest has decreased by 82.3%.
Days to Cover History
Days to cover for Bioinvent Intern (BOVNF) currently stands at 5.0 days, down 99.5% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 99.5% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 5.0 to 1000.0 days.
BOVNF Company Profile & Sector Positioning
Bioinvent Intern (BOVNF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing BOVNF often look at related companies in the same sector, including Silence Therapeutics Plc (SLNCF), Oryzon Genomics (ORYZF), Nervgen Pharma Corp (NGENF), Hansa Medical AB (HNSBF), and Adocia (ADOCY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BOVNF's relative position within its industry.